TrialTalk™ for Cancer

Recruiting at 2 trial locations

Overseen By Cancer Connect

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Wisconsin, Madison

Disqualifiers: Previous cancer trial, Cognitive impairment

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: Unknown

30 Participants Needed

Trial Summary

What is the purpose of this trial?

This clinical trial seeks to understand patients' experiences with the healthcare team and the quality of communication between patients and doctors in cancer clinics. The main question it aims to answer is: * Does TrialTalk™ improve communication between providers and patients? Participants will complete questionnaires before and after their standard of care clinic visit.

Research Team

Monica Patel, MD

Principal Investigator

University of Wisconsin, Madison

Eligibility Criteria

This trial is for cancer patients interested in improving communication with their healthcare team. Specific eligibility criteria are not provided, so it's best to contact the study organizers for details on who can participate.

Inclusion Criteria

I have been diagnosed with cancer.

Patients: identify as Black, African American, or non-Hispanic White

Patients: can read and understand English to complete the study questionnaires

Exclusion Criteria

Patients: have moderate to severe cognitive impairment

Patients: previous enrollment in a cancer intervention clinical trial

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Providers undergo TrialTalk™ training to improve communication skills

4 weeks

Online modules

Implementation

Providers and patients use the TrialTalk™ tool during standard care visits

6 months

Monthly visits

Follow-up

Participants are monitored for the sustainability and effectiveness of the TrialTalk™ tool

1 year

Treatment Details

Interventions

• TrialTalk™

Trial Overview The intervention being studied is TrialTalk™, a tool or method designed to enhance patient-provider communication in cancer clinics. Participants will answer questionnaires before and after using TrialTalk™ during their regular clinic visits.

Participant Groups

Group I: Provider participants Experimental Treatment 1 Intervention

Cancer providers who have received TrialTalk™ training.

Group II: Patient participants Experimental Treatment 1 Intervention

Patients who are treated by a cancer provider who has received TrialTalk™ training.

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials

1,249

Recruited

3,255,000+